Get quick answers to your questions about the article from our AI researcher chatbot
{'id': 'https://openalex.org/W2616137125', 'doi': 'https://doi.org/10.2177/jsci.11.15', 'title': 'Effects of lymphokines, OK-432 and indomethacin on EB-virus specific cytotoxic T lymphocyte(EBV-CTL) activity. I. The specificity and the effects on EBV-CTL activity of normal controls.', 'display_name': 'Effects of lymphokines, OK-432 and indomethacin on EB-virus specific cytotoxic T lymphocyte(EBV-CTL) activity. I. The specificity and the effects on EBV-CTL activity of normal controls.', 'publication_year': 1988, 'publication_date': '1988-01-01', 'ids': {'openalex': 'https://openalex.org/W2616137125', 'doi': 'https://doi.org/10.2177/jsci.11.15', 'mag': '2616137125'}, 'language': 'en', 'primary_location': {'is_oa': True, 'landing_page_url': 'https://doi.org/10.2177/jsci.11.15', 'pdf_url': 'https://www.jstage.jst.go.jp/article/jsci1978/11/1/11_1_15/_pdf', 'source': {'id': 'https://openalex.org/S4210189933', 'display_name': 'Japanese Journal of Clinical Immunology', 'issn_l': '0911-4300', 'issn': ['0911-4300', '1349-7413'], 'is_oa': True, 'is_in_doaj': False, 'is_core': True, 'host_organization': 'https://openalex.org/P4310313354', 'host_organization_name': 'Japanese Society for Clinical Immunology', 'host_organization_lineage': ['https://openalex.org/P4310313354'], 'host_organization_lineage_names': ['Japanese Society for Clinical Immunology'], 'type': 'journal'}, 'license': None, 'license_id': None, 'version': 'publishedVersion', 'is_accepted': True, 'is_published': True}, 'type': 'article', 'type_crossref': 'journal-article', 'indexed_in': ['crossref'], 'open_access': {'is_oa': True, 'oa_status': 'bronze', 'oa_url': 'https://www.jstage.jst.go.jp/article/jsci1978/11/1/11_1_15/_pdf', 'any_repository_has_fulltext': False}, 'authorships': [{'author_position': 'first', 'author': {'id': 'https://openalex.org/A5001501623', 'display_name': 'Hiroshi Wakiguchi', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I4210088960', 'display_name': 'Kochi Medical School Hospital', 'ror': 'https://ror.org/013rvtk45', 'country_code': 'JP', 'type': 'healthcare', 'lineage': ['https://openalex.org/I4210088960']}], 'countries': ['JP'], 'is_corresponding': False, 'raw_author_name': 'Hiroshi Wakiguchi', 'raw_affiliation_strings': ['Department of Pediatrics, Kochi Medical School'], 'affiliations': [{'raw_affiliation_string': 'Department of Pediatrics, Kochi Medical School', 'institution_ids': ['https://openalex.org/I4210088960']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5043908810', 'display_name': 'Mikiya Fujieda', 'orcid': 'https://orcid.org/0000-0002-8975-0400'}, 'institutions': [{'id': 'https://openalex.org/I4210088960', 'display_name': 'Kochi Medical School Hospital', 'ror': 'https://ror.org/013rvtk45', 'country_code': 'JP', 'type': 'healthcare', 'lineage': ['https://openalex.org/I4210088960']}], 'countries': ['JP'], 'is_corresponding': False, 'raw_author_name': 'Mikiya Fujieda', 'raw_affiliation_strings': ['Department of Pediatrics, Kochi Medical School'], 'affiliations': [{'raw_affiliation_string': 'Department of Pediatrics, Kochi Medical School', 'institution_ids': ['https://openalex.org/I4210088960']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5031604859', 'display_name': 'Kenji Matsumoto', 'orcid': 'https://orcid.org/0000-0003-1007-5375'}, 'institutions': [{'id': 'https://openalex.org/I4210088960', 'display_name': 'Kochi Medical School Hospital', 'ror': 'https://ror.org/013rvtk45', 'country_code': 'JP', 'type': 'healthcare', 'lineage': ['https://openalex.org/I4210088960']}], 'countries': ['JP'], 'is_corresponding': False, 'raw_author_name': 'Kenji Matsumoto', 'raw_affiliation_strings': ['Department of Pediatrics, Kochi Medical School'], 'affiliations': [{'raw_affiliation_string': 'Department of Pediatrics, Kochi Medical School', 'institution_ids': ['https://openalex.org/I4210088960']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5076759089', 'display_name': 'Yuji Ohara', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I4210088960', 'display_name': 'Kochi Medical School Hospital', 'ror': 'https://ror.org/013rvtk45', 'country_code': 'JP', 'type': 'healthcare', 'lineage': ['https://openalex.org/I4210088960']}], 'countries': ['JP'], 'is_corresponding': False, 'raw_author_name': 'Yuji Ohara', 'raw_affiliation_strings': ['Department of Pediatrics, Kochi Medical School'], 'affiliations': [{'raw_affiliation_string': 'Department of Pediatrics, Kochi Medical School', 'institution_ids': ['https://openalex.org/I4210088960']}]}, {'author_position': 'last', 'author': {'id': 'https://openalex.org/A5027370596', 'display_name': 'Takanobu Kurashige', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I4210088960', 'display_name': 'Kochi Medical School Hospital', 'ror': 'https://ror.org/013rvtk45', 'country_code': 'JP', 'type': 'healthcare', 'lineage': ['https://openalex.org/I4210088960']}], 'countries': ['JP'], 'is_corresponding': False, 'raw_author_name': 'Takanobu Kurashige', 'raw_affiliation_strings': ['Department of Pediatrics, Kochi Medical School'], 'affiliations': [{'raw_affiliation_string': 'Department of Pediatrics, Kochi Medical School', 'institution_ids': ['https://openalex.org/I4210088960']}]}], 'institution_assertions': [], 'countries_distinct_count': 1, 'institutions_distinct_count': 1, 'corresponding_author_ids': [], 'corresponding_institution_ids': [], 'apc_list': None, 'apc_paid': None, 'fwci': 0.154, 'has_fulltext': True, 'fulltext_origin': 'pdf', 'cited_by_count': 1, 'citation_normalized_percentile': {'value': 0.313271, 'is_in_top_1_percent': False, 'is_in_top_10_percent': False}, 'cited_by_percentile_year': {'min': 53, 'max': 61}, 'biblio': {'volume': '11', 'issue': '1', 'first_page': '15', 'last_page': '22'}, 'is_retracted': False, 'is_paratext': False, 'primary_topic': {'id': 'https://openalex.org/T12159', 'display_name': 'Human T-cell Leukemia Virus Type 1 Infection', 'score': 0.9967, 'subfield': {'id': 'https://openalex.org/subfields/2403', 'display_name': 'Immunology'}, 'field': {'id': 'https://openalex.org/fields/24', 'display_name': 'Immunology and Microbiology'}, 'domain': {'id': 'https://openalex.org/domains/1', 'display_name': 'Life Sciences'}}, 'topics': [{'id': 'https://openalex.org/T12159', 'display_name': 'Human T-cell Leukemia Virus Type 1 Infection', 'score': 0.9967, 'subfield': {'id': 'https://openalex.org/subfields/2403', 'display_name': 'Immunology'}, 'field': {'id': 'https://openalex.org/fields/24', 'display_name': 'Immunology and Microbiology'}, 'domain': {'id': 'https://openalex.org/domains/1', 'display_name': 'Life Sciences'}}, {'id': 'https://openalex.org/T10685', 'display_name': 'Viral-Related Cancers in Immunocompromised Patients', 'score': 0.9871, 'subfield': {'id': 'https://openalex.org/subfields/2730', 'display_name': 'Oncology'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}, {'id': 'https://openalex.org/T11020', 'display_name': 'Natural Killer Cells in Immunity', 'score': 0.9384, 'subfield': {'id': 'https://openalex.org/subfields/2403', 'display_name': 'Immunology'}, 'field': {'id': 'https://openalex.org/fields/24', 'display_name': 'Immunology and Microbiology'}, 'domain': {'id': 'https://openalex.org/domains/1', 'display_name': 'Life Sciences'}}], 'keywords': [{'id': 'https://openalex.org/keywords/ctl*', 'display_name': 'CTL*', 'score': 0.8641782}, {'id': 'https://openalex.org/keywords/immunotherapy', 'display_name': 'Immunotherapy', 'score': 0.492613}], 'concepts': [{'id': 'https://openalex.org/C49382859', 'wikidata': 'https://www.wikidata.org/wiki/Q286498', 'display_name': 'Lymphokine', 'level': 3, 'score': 0.9353839}, {'id': 'https://openalex.org/C147969180', 'wikidata': 'https://www.wikidata.org/wiki/Q5014579', 'display_name': 'CTL*', 'level': 4, 'score': 0.8641782}, {'id': 'https://openalex.org/C2777371288', 'wikidata': 'https://www.wikidata.org/wiki/Q410130', 'display_name': 'Interleukin 2', 'level': 3, 'score': 0.70880204}, {'id': 'https://openalex.org/C154317977', 'wikidata': 'https://www.wikidata.org/wiki/Q376266', 'display_name': 'Cytotoxic T cell', 'level': 3, 'score': 0.64196986}, {'id': 'https://openalex.org/C2776178377', 'wikidata': 'https://www.wikidata.org/wiki/Q188269', 'display_name': 'Interferon', 'level': 2, 'score': 0.62906766}, {'id': 'https://openalex.org/C2992881475', 'wikidata': 'https://www.wikidata.org/wiki/Q193529', 'display_name': 'T lymphocyte', 'level': 3, 'score': 0.5796063}, {'id': 'https://openalex.org/C203014093', 'wikidata': 'https://www.wikidata.org/wiki/Q101929', 'display_name': 'Immunology', 'level': 1, 'score': 0.49196932}, {'id': 'https://openalex.org/C2778690821', 'wikidata': 'https://www.wikidata.org/wiki/Q212354', 'display_name': 'Cytokine', 'level': 2, 'score': 0.39690155}, {'id': 'https://openalex.org/C159047783', 'wikidata': 'https://www.wikidata.org/wiki/Q7215', 'display_name': 'Virology', 'level': 1, 'score': 0.35354915}, {'id': 'https://openalex.org/C71924100', 'wikidata': 'https://www.wikidata.org/wiki/Q11190', 'display_name': 'Medicine', 'level': 0, 'score': 0.33591565}, {'id': 'https://openalex.org/C86803240', 'wikidata': 'https://www.wikidata.org/wiki/Q420', 'display_name': 'Biology', 'level': 0, 'score': 0.3205479}, {'id': 'https://openalex.org/C8891405', 'wikidata': 'https://www.wikidata.org/wiki/Q1059', 'display_name': 'Immune system', 'level': 2, 'score': 0.19383049}, {'id': 'https://openalex.org/C167672396', 'wikidata': 'https://www.wikidata.org/wiki/Q417800', 'display_name': 'CD8', 'level': 3, 'score': 0.17799076}, {'id': 'https://openalex.org/C202751555', 'wikidata': 'https://www.wikidata.org/wiki/Q221681', 'display_name': 'In vitro', 'level': 2, 'score': 0.061094582}, {'id': 'https://openalex.org/C55493867', 'wikidata': 'https://www.wikidata.org/wiki/Q7094', 'display_name': 'Biochemistry', 'level': 1, 'score': 0.0}], 'mesh': [], 'locations_count': 1, 'locations': [{'is_oa': True, 'landing_page_url': 'https://doi.org/10.2177/jsci.11.15', 'pdf_url': 'https://www.jstage.jst.go.jp/article/jsci1978/11/1/11_1_15/_pdf', 'source': {'id': 'https://openalex.org/S4210189933', 'display_name': 'Japanese Journal of Clinical Immunology', 'issn_l': '0911-4300', 'issn': ['0911-4300', '1349-7413'], 'is_oa': True, 'is_in_doaj': False, 'is_core': True, 'host_organization': 'https://openalex.org/P4310313354', 'host_organization_name': 'Japanese Society for Clinical Immunology', 'host_organization_lineage': ['https://openalex.org/P4310313354'], 'host_organization_lineage_names': ['Japanese Society for Clinical Immunology'], 'type': 'journal'}, 'license': None, 'license_id': None, 'version': 'publishedVersion', 'is_accepted': True, 'is_published': True}], 'best_oa_location': {'is_oa': True, 'landing_page_url': 'https://doi.org/10.2177/jsci.11.15', 'pdf_url': 'https://www.jstage.jst.go.jp/article/jsci1978/11/1/11_1_15/_pdf', 'source': {'id': 'https://openalex.org/S4210189933', 'display_name': 'Japanese Journal of Clinical Immunology', 'issn_l': '0911-4300', 'issn': ['0911-4300', '1349-7413'], 'is_oa': True, 'is_in_doaj': False, 'is_core': True, 'host_organization': 'https://openalex.org/P4310313354', 'host_organization_name': 'Japanese Society for Clinical Immunology', 'host_organization_lineage': ['https://openalex.org/P4310313354'], 'host_organization_lineage_names': ['Japanese Society for Clinical Immunology'], 'type': 'journal'}, 'license': None, 'license_id': None, 'version': 'publishedVersion', 'is_accepted': True, 'is_published': True}, 'sustainable_development_goals': [], 'grants': [], 'datasets': [], 'versions': [], 'referenced_works_count': 0, 'referenced_works': [], 'related_works': ['https://openalex.org/W2616137125', 'https://openalex.org/W2417793608', 'https://openalex.org/W2395122846', 'https://openalex.org/W2184553692', 'https://openalex.org/W2133759650', 'https://openalex.org/W2078919518', 'https://openalex.org/W2065367149', 'https://openalex.org/W2021665748', 'https://openalex.org/W2017318545', 'https://openalex.org/W2009411842'], 'abstract_inverted_index': {'Epstein-Barrウイルス特異的キラーT細胞活性に及ぼすinterleukin': [0], '2': [1], '(0.2U/ml),': [2], 'interferon': [3, 6, 27, 34], 'α': [4], '(500IU/ml),': [5, 8], 'γ': [7], 'OK-432': [9], '(0.01KE/ml),': [10], 'indomethacin': [11], '(1μg/ml)の影響を正常ヒトリンパ球を用いて検討し,以下の結果を得た.キラーT活性の増強は測定前日にlymphokine,': [12], 'OK-432を添加した場合にもっとも強い傾向がみられた。10例について,キラーT活性測定8日,': [13], '4日,': [14], '1日前にinterleukin': [15], '2を添加したところ,添加時間に比例してgross': [16], '%': [17, 20], 'lysis値は上昇したが,非特異的キラー活性の増強が強く,': [18], 'net': [19], 'lysis値でみた特異的キラーT活性の増強が得られたのは1日前にinterleukin': [21], '2を添加した場合だけであった.LymphokineとOK-432はキラーT活性測定前日に,': [22], 'indomethacinはキラーT誘導開始時に添加したところ,': [23], 'interleukin': [24, 32], '2とinterferon': [25], 'αはキラーT活性を有意に増強させたが,': [26], 'γ,': [28], 'OK-432,': [29], 'indomethacinには増強効果がみられなかった.同種リンパ芽球様細胞,': [30], 'K-562細胞を標的細胞とした場合,あるいは抗体陰性例のキラーT活性はlymphokineによって増強されなかった.以上のことから,': [31], '2,': [33], 'αはEpstein-Barrウイルスに特異的なキラーT細胞活性を増強し得るものと老えられた.': [35]}, 'cited_by_api_url': 'https://api.openalex.org/works?filter=cites:W2616137125', 'counts_by_year': [], 'updated_date': '2024-09-18T03:24:47.598515', 'created_date': '2017-05-26'}